Table: Oncolys Biopharma - 6-MTH parent results
Aug 8 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2025 Jun 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 28 mln 31 mln
(-9.0 pct) (-50.2 pct)
Operating loss 1.27 loss 793 mln
Recurring loss 1.31 loss 752 mln
Net loss 1.31 loss 754 mln
EPS loss 52.85 yen loss 36.96 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T